Advertisement

Topics

Vonoprazan Provides Foundation For Newly Minted Phathom

17:53 EDT 16 May 2019 | SCRIP

Newly formed US venture Phathom, with industry veteran Tachi Yamada on board, has picked up selected rights to P-CAB molecule...

      

Related Stories

 

Original Article: Vonoprazan Provides Foundation For Newly Minted Phathom

NEXT ARTICLE

More From BioPortfolio on "Vonoprazan Provides Foundation For Newly Minted Phathom"

Advertisement
Quick Search
Advertisement
Advertisement